Collegium Pharmaceutical Inc (COLL)
31.47
-6.43
(-16.97%)
USD |
NASDAQ |
May 10, 16:00
31.40
-0.07
(-0.22%)
After-Hours: 20:00
Collegium Pharmaceutical Revenue (TTM): 566.77M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 566.77M |
| September 30, 2023 | 546.64M |
| June 30, 2023 | 536.95M |
| March 31, 2023 | 524.95M |
| December 31, 2022 | 463.93M |
| September 30, 2022 | 361.68M |
| June 30, 2022 | 313.50M |
| March 31, 2022 | 272.90M |
| December 31, 2021 | 276.87M |
| September 30, 2021 | 325.78M |
| June 30, 2021 | 326.11M |
| March 31, 2021 | 321.23M |
| December 31, 2020 | 310.02M |
| September 30, 2020 | 307.95M |
| Date | Value |
|---|---|
| June 30, 2020 | 301.71M |
| March 31, 2020 | 298.70M |
| December 31, 2019 | 296.70M |
| September 30, 2019 | 295.92M |
| June 30, 2019 | 293.16M |
| March 31, 2019 | 291.18M |
| December 31, 2018 | 280.41M |
| September 30, 2018 | 217.78M |
| June 30, 2018 | 159.55M |
| March 31, 2018 | 90.05M |
| December 31, 2017 | 28.48M |
| September 30, 2017 | 18.98M |
| June 30, 2017 | 7.443M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
272.90M
Minimum
Mar 2022
566.77M
Maximum
Dec 2023
365.34M
Average
313.50M
Median
Jun 2022
Revenue (TTM) Benchmarks
| Catalyst Pharmaceuticals Inc | 411.35M |
| Immunogen Inc (DELISTED) | 287.61M |
| AnaptysBio Inc | 17.16M |
| Recursion Pharmaceuticals Inc | 43.88M |
| Nuvalent Inc | -- |